Department of Clinical Biological Resource Bank, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
Department of Cardiology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
J Gene Med. 2022 Apr;24(4):e3405. doi: 10.1002/jgm.3405. Epub 2022 Jan 30.
Accumulating evidence suggests that several microRNA (miRNA) polymorphisms are closely associated with disease susceptibility or progression, such as in Kawasaki disease (KD). Our previous studies revealed the association of miR-149 rs2292832 T>C and miR-196a2 rs11614913 C>T polymorphisms with KD susceptibility. The present study further focused on the relationship between three miRNA polymorphisms (miR-149 rs2292832 T>C, miR-196a2 rs11614913 C>T and miR-499a rs3746444 A>G) and the risk of coronary artery aneurysm (CAA) in southern Chinese KD patients.
We evaluated 318 KD patients with CAAs and 784 patients without CAAs. TaqMan assays were used to estimate genotyping and analyze the relationship between miRNA polymorphisms (miR-149 rs2292832 T>C, miR-196a2 rs11614913 C>T and miR-499a rs3746444 A>G) and risk associations of CAA by odds ratios (ORs) and 95% confidence intervals (CIs).
We found that the miR-149 rs2292832 TC/CC genotype increased the CAA risk (adjusted OR = 1.53, 95% CI = 1.15-2.03, p = 0.003 for TC, adjusted OR = 1.63, 95% CI = 1.08-2.47, p = 0.021 for CC), whereas the miR-499a rs3746444 AG genotype decreased the CAA risk in KD patients (adjusted OR = 0.33, 95% CI = 0.25-0.45 p ≤ 0.001). Moreover, patients carrying two or three of these single nucleotide polymorphism (SNP) genotypes (rs2292832 TC/CC and rs11614913 TT and rs3746444 AA) had a higher risk for CAA than those who harbored only zero or one of these SNP genotypes.
Our results demonstrated that the miR-149 rs2292832 T>C polymorphism increased the risk of CAA in KD patients and that the miR-499a rs3746444 A>G polymorphism decreased the risk of CAA in KD patients. Further studies with larger sample sizes and different centers are needed to confirm the findings of the present study.
越来越多的证据表明,一些 microRNA(miRNA)多态性与疾病易感性或进展密切相关,例如川崎病(KD)。我们之前的研究表明,miR-149 rs2292832 T>C 和 miR-196a2 rs11614913 C>T 多态性与 KD 易感性相关。本研究进一步关注三个 miRNA 多态性(miR-149 rs2292832 T>C、miR-196a2 rs11614913 C>T 和 miR-499a rs3746444 A>G)与中国南方 KD 患者冠状动脉瘤(CAA)风险之间的关系。
我们评估了 318 例有 CAA 的 KD 患者和 784 例无 CAA 的患者。TaqMan 检测用于估计基因分型,并通过优势比(OR)和 95%置信区间(CI)分析 miRNA 多态性(miR-149 rs2292832 T>C、miR-196a2 rs11614913 C>T 和 miR-499a rs3746444 A>G)与 CAA 风险关联。
我们发现 miR-149 rs2292832 TC/CC 基因型增加了 CAA 风险(调整后的 OR=1.53,95%CI=1.15-2.03,p=0.003 对于 TC,调整后的 OR=1.63,95%CI=1.08-2.47,p=0.021 对于 CC),而 miR-499a rs3746444 AG 基因型降低了 KD 患者的 CAA 风险(调整后的 OR=0.33,95%CI=0.25-0.45,p≤0.001)。此外,携带两个或三个这些单核苷酸多态性(SNP)基因型(rs2292832 TC/CC 和 rs11614913 TT 和 rs3746444 AA)的患者比仅携带零个或一个这些 SNP 基因型的患者发生 CAA 的风险更高。
我们的研究结果表明,miR-149 rs2292832 T>C 多态性增加了 KD 患者 CAA 的风险,而 miR-499a rs3746444 A>G 多态性降低了 KD 患者 CAA 的风险。需要更大样本量和不同中心的进一步研究来证实本研究的结果。